Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1997 1
1998 1
1999 1
2001 2
2003 1
2004 2
2005 3
2006 2
2007 1
2008 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Hepatic fibrosis: molecular mechanisms and drug targets.
Lotersztajn S, Julien B, Teixeira-Clerc F, Grenard P, Mallat A. Lotersztajn S, et al. Among authors: grenard p. Annu Rev Pharmacol Toxicol. 2005;45:605-28. doi: 10.1146/annurev.pharmtox.45.120403.095906. Annu Rev Pharmacol Toxicol. 2005. PMID: 15471534 Review.
[The endocannabinoid system as a novel target for the treatment of liver fibrosis].
Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Hezode C, Mallat A, Lotersztajn S. Teixeira-Clerc F, et al. Among authors: grenard p. Pathol Biol (Paris). 2008 Feb;56(1):36-8. doi: 10.1016/j.patbio.2007.01.001. Epub 2007 Apr 6. Pathol Biol (Paris). 2008. PMID: 17412522 Review. French.
Antifibrogenic role of the cannabinoid receptor CB2 in the liver.
Julien B, Grenard P, Teixeira-Clerc F, Van Nhieu JT, Li L, Karsak M, Zimmer A, Mallat A, Lotersztajn S. Julien B, et al. Among authors: grenard p. Gastroenterology. 2005 Mar;128(3):742-55. doi: 10.1053/j.gastro.2004.12.050. Gastroenterology. 2005. PMID: 15765409
[CB1 cannabinoid receptor antagonists: a novel approach for the treatment of liver fibrosis].
Teixeira-Clerc F, Julien B, Grenard P, Tran Van Nhieu J, Deveaux V, Li L, Serriere-Lanneau V, Ledent C, Mallat A, Lotersztajn S. Teixeira-Clerc F, et al. Among authors: grenard p. Med Sci (Paris). 2006 Aug-Sep;22(8-9):683-5. doi: 10.1051/medsci/20062289683. Med Sci (Paris). 2006. PMID: 16962033 Free article. French. No abstract available.
15 results